http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112300245-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b9ed41ec71e1e3d004841f54c9eabd8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06
filingDate 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfbe52f9dbb9025d0bbbc9263f39139e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_310205baf5c2fc3564c67a26b238d27f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4ab5a78291286dd893076c2b5f73945
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e81fda2445afb1a1f12a9f5f51c764e5
publicationDate 2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112300245-A
titleOfInvention RGDS and theanine co-modified 5-fluorouracil, its synthesis, activity and application
abstract The invention discloses 5-fluorouracil modified by the following formula of RGDS and theanine. Its preparation method is disclosed, and its anti-tumor and anti-tumor metastasis activities are disclosed. Therefore, the present invention discloses its application in the preparation of anti-tumor drugs, the application in the preparation of anti-tumor metastasis drugs, and the preparation of anti-tumor and anti-tumor drugs. Application of dual-active drugs in tumor metastasis.
priorityDate 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009181088-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25201220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414701712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449831254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449097368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1378560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410068132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416119336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798

Total number of triples: 50.